Molecular Detection by PCR

<<Return to Laboratory

Requisition Forms

Reference Details

Description:

Molecular detection of Chlamydophila pneumoniae by PCR.

Test Category:
Molecular Detection
Pathogen:
Chlamydophila pneumoniae
Illnesses and Diseases:
  • Atypical pneumonia
Specimen:

Bronchoalveolar lavage (BAL) or lung biopsy. We may also perform testing on nasopharyngeal aspirate (NPA), sputum, and cerebrospinal fluid (CSF) however, please note that these specimens are not ideal for testing.  Dry swabs will not be accepted for testing; any swabs sent must be supplied in appropriate storage medium.  At least 0.5 mL of fluid sample is required for testing, and it is preferable if all samples are supplied in screw-capped tubes made of freeze-thaw and shatter-resistant plastic. 

Collection Method:

Please follow standard aseptic sampling methods for collecting specimens and ensure any tissue samples/swabs are in appropriate storage medium.

 

Specimen Processing, Storage and Shipping:

No further processing at the sending lab is required once specimens are collected according to the above instructions.  It is preferable that all specimens be frozen after collection.  If that’s not possible, then store at refrigeration temperature (2 – 8°C).   Ensure that specimens are held at the appropriate temperature when shipped to the NML (e.g. frozen specimens shipped with dry ice, refrigerated specimens with cold packs).

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

For additional guidance on the transport of infectious substances in other languages, please click on the link below.

http://www.who.int/ihr/capacity-strengthening/infectious-substances/en/

Patient Criteria:

Symptoms of respiratory infection (e.g. bronchitis, atypical pneumonia) are indicative of possible C. pneumoniae infection. However it has also been associated with other disorders such as coronary artery disease, asthma, and sarcoidosis1

 

Accompanying Documentation:

Completed Special Bacteriology requisition form detailing all patient information and relevant clinical information. If possible, attach lab results that have already been done at local or provincial laboratories.

 

Comments:

If a test performed by the submitting lab produced a positive result for C. pneumoniae, it is also helpful to indicate this in the documentation including what type of test was performed.

Methods and Interpretation of Results:

DNA from all C. pneumoniae samples received at the NML for PCR testing is initially extracted using a commercially-available kit. Results are based upon a real-time PCR assay targeting argR, the conserved gene encoding the arginine repressor protein within C. pneumoniae

 

Turnaround Time:

10 calendar days. Please note that during times when large numbers of samples are received or if tests must be repeated the turnaround time may be longer.

Contact:
Phone: (204) 789-2137
Fax: (204) 784-7509
References:
  1. Thurman, K. A., Warner, A. K., Cowart, K. C., Benitez, A. J., & Winchell, J. M. (2011). Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagnostic microbiology and infectious disease, 70(1), 1-9.
Fact Sheets:
Guidelines:
Related Information: